Sinopharm
1099.HK
#2842
Rank
S$7.96 B
Marketcap
S$2.55
Share price
-3.61%
Change (1 day)
-22.19%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Earnings for Sinopharm (1099.HK)

Earnings in 2025: S$3.10 Billion

According to Sinopharm's latest financial reports the company's current earnings are S$82.21 Billion. In 2025 the company made an earning of S$3.10 Billion, an increase over its 2024 earnings that were of S$2.91 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sinopharm from 2006 to 2025

Annual earnings

Year Earnings Change
2025S$3.10 B6.59%
2024S$2.91 B-27.86%
2023S$4.03 B-0.73%
2022S$4.06 B-1.72%
2021S$4.13 B11.7%
2020S$3.70 B18.44%
2019S$3.12 B10.85%
2018S$2.82 B3.05%
2017S$2.73 B36.48%
2016S$2.00 B7.11%
2015S$1.87 B12.38%
2014S$1.66 B25.05%
2013S$1.33 B22.54%
2012S$1.08 B35.43%
2011S$0.80 B52.24%
2010S$0.52 B30.99%
2009S$0.40 B60.59%
2008S$0.25 B48.29%
2007S$0.16 B123.29%
2006S$75.76 M